Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis

Psoriasis is a chronic inflammatory skin disease affecting 2.5–6 million patients in the United States. The cause of psoriasis remains unknown. Previous human and animal studies suggest that patients with a susceptible genetic background and some stimulus, such as barrier disruption, leads to a coor...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbiser, Jack L., Nowak, Ron, Michaels, Kellie, Skabytska, Yuliya, Biedermann, Tilo, Lewis, Monica J., Bonner, Michael Y., Rao, Shikha, Gilbert, Linda C., Yusuf, Nabiha, Karlsson, Isabella, Fritz, Yi, Ward, Nicole L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593857/
https://www.ncbi.nlm.nih.gov/pubmed/28894119
http://dx.doi.org/10.1038/s41598-017-10580-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593857/
https://www.ncbi.nlm.nih.gov/pubmed/28894119
http://dx.doi.org/10.1038/s41598-017-10580-y

Ejemplares similares